CSL Ltd (CSL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CSL Ltd (CSL) has a cash flow conversion efficiency ratio of 0.114x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$2.44 Billion ≈ $1.73 Billion USD) by net assets (AU$21.48 Billion ≈ $15.20 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of CSL Ltd to measure how many days the company can operate on defensive assets alone.
CSL Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how CSL Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CSL Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CSL Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KB Financial Group Inc
F:KBIA
|
0.122x |
|
Honda Motor Co Ltd ADR
NYSE:HMC
|
0.024x |
|
SUMITOMO CORP. SP. ADR 1
F:SUMB
|
N/A |
|
FUJITSU LTD. ADR 5/1
F:FUJA
|
N/A |
|
Malayan Banking Bhd
KLSE:1155
|
-0.198x |
|
VOLKSWAGEN ADR 1/10/O.N.
F:VOWA
|
0.024x |
|
Samsung SDI
KO:006400
|
-0.010x |
|
Volkswagen AG
XETRA:VOW
|
0.027x |
Annual Cash Flow Conversion Efficiency for CSL Ltd (1993–2025)
The table below shows the annual cash flow conversion efficiency of CSL Ltd from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see CSL market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$21.41 Billion ≈ $15.15 Billion |
AU$3.56 Billion ≈ $2.52 Billion |
0.166x | +14.75% |
| 2024-06-30 | AU$19.40 Billion ≈ $13.73 Billion |
AU$2.81 Billion ≈ $1.99 Billion |
0.145x | -0.59% |
| 2023-06-30 | AU$26.78 Billion ≈ $18.95 Billion |
AU$3.91 Billion ≈ $2.76 Billion |
0.146x | -18.82% |
| 2022-06-30 | AU$21.20 Billion ≈ $15.00 Billion |
AU$3.81 Billion ≈ $2.69 Billion |
0.180x | -68.69% |
| 2021-06-30 | AU$8.42 Billion ≈ $5.96 Billion |
AU$4.83 Billion ≈ $3.42 Billion |
0.574x | +3.87% |
| 2020-06-30 | AU$6.53 Billion ≈ $4.62 Billion |
AU$3.61 Billion ≈ $2.55 Billion |
0.552x | +80.95% |
| 2019-06-30 | AU$5.27 Billion ≈ $3.73 Billion |
AU$1.61 Billion ≈ $1.14 Billion |
0.305x | -30.70% |
| 2018-06-30 | AU$4.10 Billion ≈ $2.90 Billion |
AU$1.81 Billion ≈ $1.28 Billion |
0.440x | +10.14% |
| 2017-06-30 | AU$3.16 Billion ≈ $2.24 Billion |
AU$1.27 Billion ≈ $895.30 Million |
0.400x | -13.70% |
| 2016-06-30 | AU$2.61 Billion ≈ $1.84 Billion |
AU$1.21 Billion ≈ $855.00 Million |
0.463x | -28.30% |
| 2015-06-30 | AU$2.09 Billion ≈ $1.48 Billion |
AU$1.35 Billion ≈ $955.34 Million |
0.646x | +50.61% |
| 2014-06-30 | AU$3.16 Billion ≈ $2.24 Billion |
AU$1.36 Billion ≈ $960.20 Million |
0.429x | -8.75% |
| 2013-06-30 | AU$3.01 Billion ≈ $2.13 Billion |
AU$1.41 Billion ≈ $1.00 Billion |
0.470x | +42.26% |
| 2012-06-30 | AU$3.55 Billion ≈ $2.51 Billion |
AU$1.17 Billion ≈ $830.42 Million |
0.331x | +26.49% |
| 2011-06-30 | AU$4.17 Billion ≈ $2.95 Billion |
AU$1.09 Billion ≈ $770.47 Million |
0.261x | -19.86% |
| 2010-06-30 | AU$3.02 Billion ≈ $2.14 Billion |
AU$984.78 Million ≈ $696.79 Million |
0.326x | +40.32% |
| 2009-06-30 | AU$3.52 Billion ≈ $2.49 Billion |
AU$819.29 Million ≈ $579.70 Million |
0.232x | -9.13% |
| 2008-06-30 | AU$2.68 Billion ≈ $1.90 Billion |
AU$686.77 Million ≈ $485.93 Million |
0.256x | +2.38% |
| 2007-06-30 | AU$1.63 Billion ≈ $1.15 Billion |
AU$407.51 Million ≈ $288.34 Million |
0.250x | -29.34% |
| 2006-06-30 | AU$1.09 Billion ≈ $771.10 Million |
AU$385.40 Million ≈ $272.69 Million |
0.354x | -1.48% |
| 2005-06-30 | AU$1.20 Billion ≈ $847.57 Million |
AU$430.00 Million ≈ $304.25 Million |
0.359x | +257.37% |
| 2004-06-30 | AU$1.45 Billion ≈ $1.03 Billion |
AU$145.66 Million ≈ $103.06 Million |
0.100x | -32.26% |
| 2003-06-30 | AU$586.80 Million ≈ $415.20 Million |
AU$87.02 Million ≈ $61.57 Million |
0.148x | +44.75% |
| 2002-06-30 | AU$716.77 Million ≈ $507.16 Million |
AU$73.43 Million ≈ $51.96 Million |
0.102x | -64.51% |
| 2001-06-30 | AU$229.78 Million ≈ $162.58 Million |
AU$66.33 Million ≈ $46.93 Million |
0.289x | +161.00% |
| 2000-06-30 | AU$284.37 Million ≈ $201.21 Million |
AU$31.45 Million ≈ $22.25 Million |
0.111x | -3.14% |
| 1999-06-30 | AU$184.19 Million ≈ $130.32 Million |
AU$21.03 Million ≈ $14.88 Million |
0.114x | -0.64% |
| 1998-06-30 | AU$149.53 Million ≈ $105.80 Million |
AU$17.19 Million ≈ $12.16 Million |
0.115x | -27.52% |
| 1997-06-30 | AU$273.59 Million ≈ $193.58 Million |
AU$43.38 Million ≈ $30.70 Million |
0.159x | -25.13% |
| 1996-06-30 | AU$212.25 Million ≈ $150.18 Million |
AU$44.96 Million ≈ $31.81 Million |
0.212x | +20.46% |
| 1995-06-30 | AU$167.67 Million ≈ $118.64 Million |
AU$29.48 Million ≈ $20.86 Million |
0.176x | +45.60% |
| 1994-06-30 | AU$231.32 Million ≈ $163.68 Million |
AU$27.94 Million ≈ $19.77 Million |
0.121x | -13.21% |
| 1993-06-30 | AU$70.25 Million ≈ $49.71 Million |
AU$9.78 Million ≈ $6.92 Million |
0.139x | -- |
About CSL Ltd
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma produ… Read more